Atom Investors’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.36M Buy
+184,472
New +$3.68M 0.19% 97
2026
Q2
– Sell
-15,807
Closed -$395K – 982
2026
Q1
$395K Buy
15,807
+4,222
+36% +$119K 0.03% 512
2025
Q4
$364K Sell
11,585
-11,171
-49% -$370K 0.03% 424
2025
Q3
$812K Buy
+22,756
New +$1.04M 0.06% 279
2022
Q4
– Sell
-12,686
Closed -$526K – 299
2022
Q3
$526K Sell
12,686
-2,024
-14% -$80.7K 0.19% 148
2022
Q2
$481K Buy
+14,710
New +$535K 0.21% 117

Other funds holding PRCT

Atom Investors's PRCT Position: Q3 2026 in Review

Atom Investors opened a new position in Procept Biorobotics (PRCT) in Q3 2026: 184,472 shares worth $3.36M. The stake represents 0.19% of the portfolio and ranks #97 among its holdings. This is a return to the name: Atom Investors previously reported a position in PRCT as recently as Q1 2026.

Atom Investors first reported a position in PRCT in Q2 2022 and has held it in 6 quarters since. 231 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Atom Investors held 184,472 shares of Procept Biorobotics worth $3.36M as of Q3 2026.
  • Procept Biorobotics was a new Atom Investors position in Q3 2026.
  • Procept Biorobotics made up 0.19% of Atom Investors's portfolio in Q3 2026, its #97 holding.
  • Atom Investors first reported a position in Procept Biorobotics in Q2 2022 and has held it in 6 quarters since.
  • 231 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Atom Investors's 13F filing for Q3 2026, filed 16 Nov 2026.